OrganaBio
OrganaBio is a contract technology development and manufacturing organization (CTDMO) that manufactures clinical (cGMP) grade cells for cancer immunotherapy and regenerative medicine drug developers. OrganaBio’s vision is to accelerate the development of these drugs by giving developers access to:
- Fresh and scalable tissue supplies
- Cell isolation, purification, expansion, cryopreservation, and characterization services
- Process development services
- Clinical-grade manufacturing services.
Whether you desire cellular starting material, clinical trial services, process and assay development, or manufacturing across the cell therapy continuum, OrganaBio provides access to these critical resources essential for therapeutic development while adhering to high standards of quality assurance and regulatory compliance. At OrganaBio, we empower our customers’ people, process, and products on their journey to commercialization.
Not only is OrganaBio exhibiting at booth 337 and would welcome the opportunity to learn more about your programs and needs, but we are also providing exclusive invitations to our pre-conference reception and a tour of our cGMP manufacturing facility – located just 30 minutes from the convention center – on January 17 between 1-3pm. Please contact our Director of Marketing, Shilpa Ramesh (Shilpa.ramesh@organabio.com) to request an invitation to the reception or to schedule a meeting with the OrganaBio team.
